Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elena Ocheredko"'
Autor:
Elena Ocheredko, Nadezhda Lukashevich, Maria Savchenko, Sofia Kust, Syune Ambaryan, Dmitry Tabakov, Maria Sorokina, Linda Balabanian, Kushal Suryamohan, Anastasiya Zotova, Nathan Fowler, Aleksander Bagaev
Publikováno v:
Cancer Research. 83:6538-6538
Functional gene expression signatures (FGES) are widely used as biomarkers in cancer diagnostics as descriptive and predictive models for treatment selection. Since FGES scores are based solely on gene expression profiles, they can be applied to data
Autor:
Elena Ocheredko, Svetlana Khmelevskaya
Publikováno v:
Ideas and Ideals. 12:134-151
The subject of the research is the philosophical (ontological, epistemological, philosophical-anthropological and social-philosophical) foundations of personalized medicine, the biomedical foundations of which are methods of therapy and prevention of
Autor:
Cody A. Ramirez, Felix Frenkel, Michelle Becker-Hapak, Erica K. Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L. Skidmore, Marcus P. Watkins, Thomas B. Mooney, Jason R. Walker, Kilannin Krysiak, David A. Russler-Germain, Felicia Gomez, Catrina C. Fronick, Robert S. Fulton, Robert D. Schreiber, Neha Mehta-Shah, Amanda F. Cashen, Brad S. Kahl, Ravshan Ataullakhanov, Nancy L. Bartlett, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Personalized cancer vaccines designed to target neoantigens represent a promising new treatment paradigm in oncology. In contrast to classical idiotype vaccines, we hypothesized that ‘polyvalent’ vaccines could be engineered for the personalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b922592ebecde45a7413123710bd2365
https://doi.org/10.1101/2022.01.06.22268805
https://doi.org/10.1101/2022.01.06.22268805
Autor:
Elena Ocheredko, Jason Walker, Ataullakhanov Ravshan I, Todd A. Fehniger, Catrina Fronick, Alexander Bagaev, Michelle Becker-Hapak, Cody Ramirez, Robert S. Fulton, Vladislav Belousov, Nancy L. Bartlett, Susanna Kiwala, Malachi Griffith, Olga Plotnikova, Felix Frenkel, Jasreet Hundal, Thomas B. Mooney, Zachary L. Skidmore, Obi L. Griffith, Brad S. Kahl, Marcus Watkins, Robert D. Schreiber
Publikováno v:
Blood Cancer Discovery. 1:PO-56
Follicular lymphoma (FL) is the most common indolent non-Hodgkin's lymphoma; however, it remains incurable with conventional therapies and is poorly responsive to checkpoint blockade. Additionally, because FL develops so slowly (and often asymptomati
Autor:
Marcus Watkins, Todd A. Fehniger, Cody Ramirez, Thomas B. Mooney, Alexander Bagaev, Malachi Griffith, Obi L. Griffith, Robert S. Fulton, Jasreet Hundal, Olga Plotnikova, Zachary L. Skidmore, Michelle Becker-Hapak, Brad S. Kahl, Felix Frenkel, Elena Ocheredko, Ataullakhanov Ravshan I, Nancy L. Bartlett, Susanna Kiwala, Robert D. Schreiber, Vladislav Belousov, Jason Walker, Catrina Fronick
Publikováno v:
Cancer Genetics. 244:17
Autor:
Marcus Watkins, Ataullakhanov Ravshan I, Malachi Griffith, Cody Ramirez, Michelle Becker-Hapak, Robert D. Schreiber, Susanna Kiwala, Robert S. Fulton, Nancy L. Bartlett, Vladislav Belousov, Elena Ocheredko, Alexander Bagaev, Felix Frenkel, Skidmore Zl, Olga Plotnikova, Todd A. Fehniger, Brad S. Kahl, Catrina Fronick, Obi L. Griffith, Jasreet Hundal
Publikováno v:
Journal of Clinical Oncology. 38:8054-8054
8054 Background: Follicular lymphoma (FL) is incurable with conventional therapies and poorly responsive to immune checkpoint blockade. There is a need for new therapies without long-term complications of chemotherapy and with curative potential. We